Century(SZ:300078) Shen Zhen Shang Bao·2026-01-03 11:24Core Viewpoint - The company, Sichuang Medical Technology Co., Ltd., is facing legal scrutiny for alleged fraudulent issuance of securities and improper disclosure of important information, with the case now moving to the prosecution stage [3][4][5]. Group 1: Legal Proceedings - The company received a notice from the Hangzhou Public Security Bureau regarding the transfer of the case to the Hangzhou People's Procuratorate for prosecution, indicating that the investigation has concluded with clear criminal facts and sufficient evidence [4][5]. - The case originated from the company's public issuance of convertible bonds amounting to 817 million yuan in 2021, during which it allegedly fabricated financial data for 2019 and 2020 through fictitious business activities and inflated revenue [5][6]. - The actual controller, Zhang Lizhong, has been banned from the market due to his role in orchestrating the financial fraud, which included concealing related party fund usage [6][7]. Group 2: Company Operations and Strategy - Despite the ongoing legal issues, the company claims that its production and operational activities are running normally and that it will cooperate with the legal proceedings while protecting the rights of its shareholders [4][5]. - The company is undergoing a transformation focusing on compliance and core business, with plans to optimize its name and business scope to reflect its strategic direction in the Internet of Things sector [4][7]. - As of the third quarter of 2025, the company reported a revenue of 604 million yuan, a year-on-year increase of 7%, while reducing its net loss from 284 million yuan to 4.76 million yuan [7][8].